Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
about
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionIntravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionClearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degenerationA review of drug options in age-related macular degeneration therapy and potential new agents.Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusionInterventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.The problem of pressure elevation associated with intravitreal triamcinolone.Development of biodegradable controlled release scleral systems of triamcinolone acetonide.Intravitreal micronized triamcinolone versus triamcinolone acetonide: a clinical and morphological comparative study.Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model.Retinal vascular injuries and intravitreal human embryonic stem cell-derived haemangioblasts.Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.
P2860
Q24187275-91C31A43-8410-4494-A859-E6BD35A6A322Q24240914-22854321-89C6-4D1E-92F9-B7884F0329E8Q30821147-F8D128D9-35C2-4ABC-BA83-562BCF68524DQ33263803-F2271B57-D404-42F9-BE4E-D201C53948DFQ33771437-3D7A0D1C-95DE-4CA0-AE0F-A271B1982CE2Q34786343-61707723-A3AF-4228-8236-FDE8433CC7A2Q35762482-B05A51CD-E73E-412D-AE34-FCDFE96EF2F4Q36191344-01D50DD7-7EDE-4388-83A0-2905F087665EQ37233253-51D58DBA-ECB1-4145-81D2-7BC4E36085D4Q37477129-C6CFF986-9C58-41D4-ACFF-B0C7BC041C54Q37879167-4A79923E-87E0-4C1B-8D69-8AA7CC2894A4Q42841761-79588852-95C7-4CAB-B0A8-4933DBEB48A4Q42881021-E587972F-138C-4E15-A368-6EE675341A45Q46705545-EDBE29CD-85AD-44A2-B27B-8463C34F2466Q48222355-715C52BA-30FD-4862-B9D2-E08C6D77C442Q48245382-10C18230-808F-49F7-808B-C97B317924D0Q49224656-AF758D08-CCFC-4475-827B-5FD98FA482F4
P2860
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@ast
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@en
type
label
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@ast
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@en
prefLabel
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@ast
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@en
P2860
P1433
P1476
Intravitreal triamcinolone ace ...... tous and neovascular diseases.
@en
P2860
P304
P356
10.1111/J.1600-0420.2005.00592.X
P50
P577
2005-12-01T00:00:00Z